[go: up one dir, main page]

KORNGOLD et al., 1994 - Google Patents

Graft-versus-myeloid leukemia responses following syngeneic and allogeneic bone marrow transplantation

KORNGOLD et al., 1994

Document ID
18379087763472052313
Author
KORNGOLD R
LEIGHTON C
MANSER T
Publication year
Publication venue
Transplantation

External Links

Snippet

A model for investigating graft-versus-leukemia (GVL) activity following syngeneic and MHC- compatible allogeneic BMT has been developed in C57BL/6 (B6) mice with use of the c-myc retrovirus-transformed MMB3. 19 myeloid leukemia line. The MMB3. 19 line was derived …
Continue reading at journals.lww.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells

Similar Documents

Publication Publication Date Title
KORNGOLD et al. Graft-versus-myeloid leukemia responses following syngeneic and allogeneic bone marrow transplantation
Spangrude et al. Purification and characterization of mouse hematopoietic stem cells
Knight et al. Non-adherent, low-density cells from human peripheral blood contain dendritic cells and monocytes, both with veiled morphology
Negrin et al. Transplantation of highly purified CD34+ Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer
Prentice et al. Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia
Luhm et al. Large-scale generation of natural killer lymphocytes for clinical application
Uchida et al. Rapid and sustained hematopoietic recovery in lethally irradiated mice transplanted with purified Thy-1.1 lo Lin-Sca-1+ hematopoietic stem cells
Zhang et al. Dendritic cell–activated CD44hiCD8+ T cells are defective in mediating acute graft-versus-host disease but retain graft-versus-leukemia activity
Wells et al. A technique for the separation and cryopreservation of myeloid stem cells from human bone marrow
Freedman et al. Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy
Vose et al. Transplantation of highly purified CD34+ Thy-1+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma
HU205380B (en) Simplified process for producing killer cells activated with human lymphokine
Gluckman et al. Umbilical cord blood transplants
Ogata et al. Long-term repopulation of hematolymphoid cells with only a few hemopoietic stem cells in mice.
SHELToN et al. Mediation of skin allograft rejection in scid mice by CD4+ and CD8+ T cells
Pfeffer et al. Cell mediated lympholysis: a one step microplate technique
Kedar et al. Studies on the Induction and Expression of T Cell-Mediated Immunity: IV. Non-Overlapping Populations of Alloimmune Cytotoxic Lymphocytes with Specificity for Tumor-Associated Antigens and Transplantation Antigens
Keever-Taylor et al. Complement-mediated T-cell depletion of bone marrow: comparison of T10B9. 1A-31 and Muromonab-Orthoclone OKT3
AU6125486A (en) Process and composition for treatment of cancer and non- malignant tumors
Noga et al. Characterization of the natural suppressor cell population in adult rat bone marrow
JP3917652B2 (en) Hematopoietic promoting cells and uses thereof
Dantas et al. Detection of melanoma cells in bone marrow using monoclonal antibodies (a comparison of fluorescence activated cell sorting (FACS) and conventional immunofluorescence (IF))
Platsoucas et al. The use of magnetic monosized polymer particles for the removal of T cells from human bone marrow cell suspensions
US4772469A (en) Production of lymphoid tissue effector cells reactive against cancer cells by means of MER, and use thereof in cancer therapy
Rameshwar et al. Endogenous hematopoietic reconstitution induced by human umbilical cord blood cells in immunocompromised mice: implications for adoptive therapy